https://www.selleckchem.com/pr....oducts/muvalaplin.ht
The primary outcome is the proportion of participants who achieve ≥ 4-fold RPR titer decrease at 3 or 6months post-treatment. Clinical trials evaluating the efficacy of alternative antibiotics to penicillin are urgently needed. Clinicaltrials.gov NCT03660488 . Registered on 4 September 2018. Clinicaltrials.gov NCT03660488 . Registered on 4 September 2018. Haem is a key metabolic factor in the life cycle of the malaria parasite. In the blood stage, the parasite acquires host haemoglobin to generate amino acids for protein synthesis an
Like
Comment
Share
